Biofire
Timothee de Mierry has had a long and varied career in finance, beginning in 2004 when they joined UBS Investment Bank as an Associate Director in the Global Healthcare Group. From there, they moved to Magnetar Capital in 2008 as an Investment Associate in the European Risk Arbitrage group. In 2009, they joined Macquarie Bank in a similar role and then moved to Exane in 2011. In 2013, they joined MARKET SECURITIES (A Kyte Group Company) as a European Equity Special Situations Analyst. In 2014, they joined Ledbury Capital Partners LLP as a Senior Investment Analyst. In 2017, they joined MCap Group as a Global Investment Director. In 2018, they joined Biofire as Chief Financial Officer and Advisor to the CEO & Founder. In 2019, they joined Palantir Technologies as a Strategic Development and Amobee as an Advisor.
Timothee de Mierry obtained their B.S. in Aeronautics/Astronautics from the Massachusetts Institute of Technology between 2000 and 2004. Prior to that, they attended Seoul Foreign High School from 1996 to 2000 and obtained an International Baccalaureate. In September 2018, Timothee de Mierry obtained a Chartered Financial Analyst (CFA) certification from the CFA Institute.
This person is not in any offices
Biofire
1 followers
Biofire’s mission is to redesign firearms from the ground up for the 21st century, bringing much-needed innovation to a space that has seen little innovation in 50 years. Named the “Tesla of the gun world” by the WSJ, Biofire is enabling radically safer ownership of firearms. A technological solution that sidesteps the political conversation around guns, Biofire’s Smart Gun™ is uniquely able to prevent avoidable and accidental gun deaths. By offering gun owners the option of a Smart Gun™ that only they can use, we are empowering them with full control over their firearm so that the next time a child or teenager finds a gun, it will be locked and unusable. This is just the beginning of the improvements we will bring to market by solving the hard problems and rethinking every aspect to create the modern firearm. Biofire has received international recognition in the WSJ, NYT, Bloomberg, Fast Company, and many more for our industry-changing technology. We are backed by expert investors, founders, and advisors